These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 33179609)

  • 1. Probing spatiotemporal fractionation on the preclinical level.
    Telarovic I; Krayenbuehl J; Grgic I; Tschanz F; Guckenberger M; Pruschy M; Unkelbach J
    Phys Med Biol; 2020 Nov; 65(22):22NT02. PubMed ID: 33179609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spatiotemporal fractionation schemes for stereotactic radiosurgery of multiple brain metastases.
    Torelli N; Papp D; Unkelbach J
    Med Phys; 2023 Aug; 50(8):5095-5114. PubMed ID: 37318898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of increased cell loss on the repopulation rate during fractionated irradiation in human FaDu squamous cell carcinoma growing in nude mice.
    Hessel F; Petersen C; Zips D; Krause M; Pfitzmann D; Thames HD; Baumann M
    Int J Radiat Biol; 2003 Jul; 79(7):479-86. PubMed ID: 14530155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contrast-enhanced, conebeam CT-based, fractionated radiotherapy and follow-up monitoring of orthotopic mouse glioblastoma: a proof-of-concept study.
    Stegen B; Nieto A; Albrecht V; Maas J; Orth M; Neumaier K; Reinhardt S; Weick-Kleemann M; Goetz W; Reinhart M; Parodi K; Belka C; Niyazi M; Lauber K
    Radiat Oncol; 2020 Jan; 15(1):19. PubMed ID: 31969174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A treatment planning study evaluating a 'simultaneous integrated boost' technique for accelerated radiotherapy of stage III non-small cell lung cancer.
    Dirkx ML; van Sörnsen De Koste JR; Senan S
    Lung Cancer; 2004 Jul; 45(1):57-65. PubMed ID: 15196735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective inhibition of the epidermal growth factor receptor tyrosine kinase by BIBX1382BS and the improvement of growth delay, but not local control, after fractionated irradiation in human FaDu squamous cell carcinoma in the nude mouse.
    Baumann M; Krause M; Zips D; Eicheler W; Dörfler A; Ahrens J; Petersen C; Brüchner K; Hilberg F
    Int J Radiat Biol; 2003 Jul; 79(7):547-59. PubMed ID: 14530164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of the tumour bed effect on microenvironment, radiobiological hypoxia and the outcome of fractionated radiotherapy of human FaDu squamous-cell carcinoma growing in the nude mouse.
    Zips D; Eicheler W; Brüchner K; Jackisch T; Geyer P; Petersen C; van der Kogel AJ; Baumann M
    Int J Radiat Biol; 2001 Dec; 77(12):1185-93. PubMed ID: 11747543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Robust spatiotemporal fractionation schemes in the presence of patient setup uncertainty.
    Gaddy MR; Unkelbach J; Papp D
    Med Phys; 2019 Jul; 46(7):2988-3000. PubMed ID: 31087677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Semi-automatic cone beam CT segmentation of in vivo pre-clinical subcutaneous tumours provides an efficient non-invasive alternative for tumour volume measurements.
    Brodin NP; Tang J; Skalina K; Quinn TJ; Basu I; Guha C; Tomé WA
    Br J Radiol; 2015 Jun; 88(1050):20140776. PubMed ID: 25823502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiobiological hypoxia, oxygen tension, interstitial fluid pressure and relative viable tumour area in two human squamous cell carcinomas in nude mice during fractionated radiotherapy.
    Baumann M; Appold S; Zimmer J; Scharf M; Beuthien-Baumann B; Dubben HH; Enghardt W; Schreiber A; Eicheler W; Petersen C
    Acta Oncol; 2001; 40(4):519-28. PubMed ID: 11504313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Responses of an experimental solid tumour to irradiation: A comparison of modes of fractionation.
    Schenken LL; Poulakos L; Hagemann RF
    Br J Cancer; 1975 Feb; 31(2):228-36. PubMed ID: 809050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imaging and Dosimetry Study of Inter-fraction Setup Error in a Murine Xenograft Flank Tumor Radiation Model.
    Smith EJ; Tryggestad EJ; Carlson BL; Walb MC; Sarkaria JN
    Radiat Res; 2020 Feb; 193(2):161-170. PubMed ID: 31877254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer: 5-year outcomes of the HYPO-RT-PC randomised, non-inferiority, phase 3 trial.
    Widmark A; Gunnlaugsson A; Beckman L; Thellenberg-Karlsson C; Hoyer M; Lagerlund M; Kindblom J; Ginman C; Johansson B; Björnlinger K; Seke M; Agrup M; Fransson P; Tavelin B; Norman D; Zackrisson B; Anderson H; Kjellén E; Franzén L; Nilsson P
    Lancet; 2019 Aug; 394(10196):385-395. PubMed ID: 31227373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Time benefit in the assessment of recurrences following fractionated radiotherapy in an experimental tumour system using positron-emission tomography with 18F-fluorodeoxyglucose.
    De Wit M; Raabe A; Seegers B; Buchert R; Beck-Bornholdt HP; Alberti W; Hossfeld DK
    Int J Radiat Biol; 2004 Jul; 80(7):529-39. PubMed ID: 15360091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of increase of radiation dose on local control relates to pre-treatment FDG uptake in FaDu tumours in nude mice.
    Schütze C; Bergmann R; Yaromina A; Hessel F; Kotzerke J; Steinbach J; Baumann M; Beuthien-Baumann B
    Radiother Oncol; 2007 Jun; 83(3):311-5. PubMed ID: 17502117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer (HYPO-RT-PC): patient-reported quality-of-life outcomes of a randomised, controlled, non-inferiority, phase 3 trial.
    Fransson P; Nilsson P; Gunnlaugsson A; Beckman L; Tavelin B; Norman D; Thellenberg-Karlsson C; Hoyer M; Lagerlund M; Kindblom J; Ginman C; Johansson B; Björnlinger K; Seke M; Agrup M; Zackrisson B; Kjellén E; Franzén L; Widmark A
    Lancet Oncol; 2021 Feb; 22(2):235-245. PubMed ID: 33444529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumour oxygenation during fractionated radiotherapy--comparison with size-matched controls.
    Stüben G; Thews O; Pöttgen C; Stuschke M; Sack H
    Acta Oncol; 1999; 38(2):209-13. PubMed ID: 10227443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PET hypoxia imaging with FAZA: reproducibility at baseline and during fractionated radiotherapy in tumour-bearing mice.
    Busk M; Mortensen LS; Nordsmark M; Overgaard J; Jakobsen S; Hansen KV; Theil J; Kallehauge JF; D'Andrea FP; Steiniche T; Horsman MR
    Eur J Nucl Med Mol Imaging; 2013 Jan; 40(2):186-97. PubMed ID: 23076620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo effects of lattice radiation therapy on local and distant lung cancer: potential role of immunomodulation.
    Kanagavelu S; Gupta S; Wu X; Philip S; Wattenberg MM; Hodge JW; Couto MD; Chung KD; Ahmed MM
    Radiat Res; 2014 Aug; 182(2):149-62. PubMed ID: 25036982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypofractionated irradiation for non-small cell lung cancer.
    Abratt RP; Bogart JA; Hunter A
    Lung Cancer; 2002 Jun; 36(3):225-33. PubMed ID: 12009230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.